An observational study in Gunshot Wound, Obesity & Overweight and Abdominal Injuries, sponsored by Bakirkoy Dr. Sadi Konuk Research and Training Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.
Sponsored by Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Observational
Among 352 studies in Obesity with a site in Turkey — 72 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.
Among the 352 studies in Obesity with a site in Turkey, this one is the 55th largest by enrollment of the 160 observational ones, is one of 59 that started in 2026, is one of 160 observational ones, and was the 326th registered.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
This study's enrollment of 112 is close to the median of 114 across 2,154 observational studies indexed under Obesity.
Browse Obesity studies →72 of the 352 studies in Obesity with a site in Turkey are open now, in 12 countries. Each count lists the studies.
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 168 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →352 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 59 started in 2026.
Median enrollment 64 across the 191 interventional studies, 82 across the 160 observational. Of the 236 that completed or were terminated, 7 (3%) have results posted.
34 of 352 have an industry lead sponsor. The 10 most frequent:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital is the lead sponsor of 122 studies on the registry; 14 are open to participants now.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital has 5 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
34 of the studies in Obesity with a site in Turkey that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05556512Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | 2027-10 |
| NCT07769736Istinye UniversityMotivational Interviews Based on the Five-Step (5A) Model on Obesity Risk | 2026-11 |
| NCT07652151Fundación Pública Andaluza para la gestión de la Investigación en SevillaUNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers | 2026-11 |
| NCT07878299Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyComparison of Segmental Body Composition Characteristics in Lipedema and Obesity | 2026-11-20 |
| NCT07846956Istanbul Saglik Bilimleri UniversityNAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study | 2026-11-30 |
Among the 352 studies in Obesity with a site in Turkey, from their registry updates:
This retrospective observational study evaluated whether obesity was associated with outcomes after surgery for thoracoabdominal or isolated abdominal gunshot injuries. Adult patients who underwent surgery for these injuries at a referral trauma center between 2020 and 2025 were included. Patients were grouped according to body mass index, with obesity defined as a body mass index of 30 kg/m² or higher. Clinical characteristics, injury-related variables, perioperative findings, postoperative complications, need for reoperation, intensive care unit stay, mechanical ventilation, hospital stay, and mortality were evaluated. The study aimed to determine whether outcomes differed between patients with and without obesity and to identify factors associated with postoperative morbidity and mortality.
This was a single-center retrospective observational cohort study of adult patients who underwent surgery for thoracoabdominal or isolated abdominal gunshot injuries at a referral trauma center between 2020 and 2025.
Patients aged 18 years or older were eligible for inclusion. Patients who died in the emergency department, arrived without signs of life, had an Abbreviated Injury Scale score of 3 or greater in another body region, or were transferred from another hospital were excluded.
Patients were categorized according to obesity status. Obesity was defined as a body mass index of 30 kg/m² or higher, and outcomes were compared with those of patients with a body mass index below 30 kg/m².
Data collected from medical records included demographic characteristics, injury-related variables, initial physiological and laboratory findings, perioperative characteristics, blood transfusion requirements, operative duration, gastrointestinal interventions, stoma creation, postoperative complications, need for reoperation, duration of mechanical ventilation, intensive care unit length of stay, total hospital length of stay, and mortality. The shock index was calculated as heart rate divided by systolic blood pressure at emergency department admission.
Postoperative morbidity was defined as any postoperative complication with a Clavien-Dindo grade of IIIa or higher. Multivariable logistic regression analyses were used to evaluate factors independently associated with morbidity and mortality, with obesity included as the primary exposure variable.
Adult patients who underwent surgery for thoracoabdominal or isolated abdominal gunshot injuries at a referral trauma center between 2020 and 2025. Eligible patients were identified retrospectively from institutional medical records.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adult patients who underwent surgery for thoracoabdominal or isolated abdominal gunshot injuries at the study center between 2020 and 2025. Patients were retrospectively evaluated and classified according to obesity status based on body mass index.
Other: Obesity Status
Obesity status was determined from body mass index (BMI). Patients with a BMI of 30 kg/m² or higher were classified as having obesity, and patients with a BMI below 30 kg/m² were classified as non-obese. Obesity status was an observed exposure and was not assigned by the investigators.
Major Postoperative Morbidity
Occurrence of one or more postoperative complications classified as Clavien-Dindo grade IIIa or higher.
Time frame: Within 30 days after surgery
Plan to share: Yes — De-identified individual participant data underlying the results reported in this study may be shared upon reasonable request to the corresponding author, subject to institutional policies and applicable ethical and data protection requirements.
No publications or documents are linked to this record.
Ran from Jun 2026 to primary completion in Jun 2026, 0 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital →